Royal Free London NHS Foundation Trust
Text size: Click to set the font size to normal

Neuroendocrine tumour unit: home

The neuroendocrine tumour (NET) unit at the Royal Free Hospital has an international reputation for the management of neuroendocrine tumour patients. In 2010 it was the first UK centre to be awarded European Centre of Excellence. It currently receives 12-20 new referrals per month (144-240 per year) and has an active patient cohort of over 1,500 patients. We receive referrals from across the UK as well as from abroad. It is the designated centre for NETs within the North London Cancer Network.

The aim of the Royal Free Hospital neuroendocrine tumour group is to provide optimal management for patients with neuroendocrine tumours, taking into account how the tumour affects each individual. We work within a multidisciplinary team and aim to enhance the prospects for treatment by a combination of clinical and laboratory research.

The RFH NET unit and oncology department conducts a number of clinical and basic science research trials relating to the treatment of and the pathogenesis of NET development. The NET unit clinicians and researchers collaborate with clinicians and research staff in the UK and abroad. The clinical lead and head of the neuroendocrine unit is Professor Martyn Caplin.

Neuroendocrine tumour unit office, 10th floor, centre for gastroenterology, Royal Free Hospital.

Making an appointment
Appointments can be made following a referral from a GP, and through the choose and book system. Tertiary referrals are also available.

Contact Us
020 7830 2867

European Neuroendocrine Tumor Society  Centre of Excellence logo

page last reviewed: 16 January 2013